Aqueous prolonged release formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/25 (2006.01)

Patent

CA 2240685

Prolonged parenteral release into the circulatory system of a cow of a bioactive growth hormone releasing factor at desirably effective levels can be achieved using novel compositions in which the growth hormone releasing factor is present in an aqueous liquid at a dose of at least about 50 mg and at a concentration of at least about 20 mg/ml. Preferably, the growth hormone releasing factor is present in an aqueous liquid at a dose of about 200 mg and at a concentration of about 180 mg/ml. The aqueous bovine somatotropin formulation provides for the sustained release of bovine somatotropin into the circulatory system of the animal for greater than seven (7) days.

La libération parentérale prolongée d'un facteur de libération d'hormone de croissance bioactif à des niveaux efficaces dans le système circulatoire d'une vache peut être obtenue à l'aide de nouvelles compositions dans lesquelles le facteur de libération d'une hormone de croissance est présent dans un liquide aqueux à une dose d'au moins 50 mg et à une concentration d'au moins 20 mg/ml environ. De préférence, le facteur de libération de l'hormone de croissance est présent dans un liquide aqueux selon une dose d'environ 200 mg et à une concentration d'environ 180 mg/ml. La formulation aqueuse de somatotropine bovine assure une libération entretenue de la somatotropine bovine dans le système circulatoire de l'animal pendant plus de 7 jours.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aqueous prolonged release formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aqueous prolonged release formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous prolonged release formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2021970

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.